Utrogestan is indicated for adjunctive use with estrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT). In women receiving estrogen replacement therapy there is an increased risk of endometrial cancer which can be countered by progesterone administration.

30pcs/box